Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2012
05/16/2012CN102451219A Fermented soya bean active substance and preparation method thereof
05/16/2012CN102451217A Manufacture method for blood pressure reducing powder
05/16/2012CN102451215A Extraction technology of gypenoside
05/16/2012CN102451210A Extraction method of effective ingredients from epimedium
05/16/2012CN102451201A Extraction process for ginkgo leaf extract for injection
05/16/2012CN102451200A Active Chinese medicine prescription for treating and treating heart disease and preparation process thereof
05/16/2012CN102451194A Extraction method for scorpion venom
05/16/2012CN102451191A Preparation method of hemorrhoid ointment
05/16/2012CN102451179A Enteric solid preparation containing lycopene, resveratrol or melatonin and preparation method of enteric solid preparation
05/16/2012CN102451177A Application of butylphthalide or derivatives thereof in preparation of medicaments for promoting angiogenesis
05/16/2012CN102451175A Resveratrol and bioflavonoid composition as well as preparation and application thereof
05/16/2012CN102451161A Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
05/16/2012CN102451158A Nimodipine-SiO2 nanospheres and preparation and application thereof
05/16/2012CN102451131A Chinese medicinal shampoo with blood pressure lowering function and preparation method thereof
05/16/2012CN102451122A Wild chrysanthemum skin lotion
05/16/2012CN102451092A Effervescent bath salt block and preparation method thereof
05/16/2012CN102450774A Health-care insole
05/16/2012CN102450358A Formula of blood pressure-lowering drinking tea and its preparation method
05/16/2012CN102450355A Preparation method of health care tea capable of treating hypertension
05/16/2012CN101732292B Novel application of tetrahydrocurcumin
05/16/2012CN101716308B Quality control method of calculus bovis antihypertensive pills
05/16/2012CN101531652B Novel method for extracting anthocyanin in bilberry by double water phases
05/16/2012CN101524470B Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof
05/16/2012CN101522191B Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
05/16/2012CN101386594B 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them
05/16/2012CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/16/2012CN101253164B Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
05/16/2012CN101228127B Novel piperidine derivative
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178574 Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide
05/15/2012US8178554 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
05/15/2012US8178514 Inositol pyrophosphates, and methods of use thereof
05/15/2012US8178493 Method for inducing angiogenesis in a heart of a patient
05/15/2012US8178489 Formulation for aviptadil
05/15/2012CA2645558C Regulation of phospholipase d activity
05/15/2012CA2643005C Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof
05/15/2012CA2542726C Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
05/15/2012CA2524323C Aminocyclohexyl ether compounds and uses thereof
05/15/2012CA2523740C Lactate containing pharmaceutical composition and uses thereof
05/15/2012CA2496329C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
05/15/2012CA2493859C Preventive/remedy for arteriosclerosis comprising adiponectin
05/15/2012CA2477593C Chemical igf-i formulation for the treatment and prevention of neurodegenerative diseases
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2448933C A retinoic acid metabolizing cytochrome p450
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/15/2012CA2422059C Methods and products related to low molecular weight heparin
05/15/2012CA2283642C Therapeutic compositions
05/10/2012WO2012061459A1 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061289A2 Methods for treatment of brain injury utilizing biologics
05/10/2012WO2012061169A1 Benzimidazole inhibitors of leukotriene production
05/10/2012WO2012060718A1 Preventing or treating metabolic syndrome by administering a trans fatty acid, or a salt, ester or precursor thereof, or sialic acid in free or bound form
05/10/2012WO2012060607A2 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
05/10/2012WO2012060431A1 Patch
05/10/2012WO2012059869A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
05/10/2012WO2012059820A1 Temperature sensitive hydrogel and block copolymers
05/10/2012WO2012059818A1 Methods of treatment using lipid compounds
05/10/2012WO2012059549A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
05/10/2012WO2012059548A1 Benzyl-substituted carbamates and use thereof
05/10/2012WO2012059543A1 Composition containing calcium carbonate
05/10/2012WO2012059507A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012WO2012059416A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/10/2012WO2012058993A1 Use of ambrisentan for preventing or alleviating cardiac function injury caused by hypoxia
05/10/2012WO2012019428A8 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
05/10/2012WO2012012347A3 Methods of intravenous administration of glyburide and other drugs
05/10/2012WO2011146589A3 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
05/10/2012US20120116051 Polymer Conjugate Of Bioactive Substance Having Hydroxy Group
05/10/2012US20120115951 Protective action of serofendic acid on cardiac muscle
05/10/2012US20120115946 Formulation
05/10/2012US20120115943 Composition and method for neuroprotection against excitotoxic injury
05/10/2012US20120115936 Potent anti apob antisense compounds
05/10/2012US20120115934 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115933 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115931 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
05/10/2012US20120115929 Means And Methods For Counteracting, Preventing And/Or Determining Heart Failure, Or A Risk Of Heart Failure
05/10/2012US20120115927 Pharmaceutical agent for preventing cell death
05/10/2012US20120115920 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
05/10/2012US20120115917 Combination therapy for the management of hypertension
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115907 Novel compounds as inhibitors of renin
05/10/2012US20120115905 Nitrone, Nitroso, and Nitroxide Spintraps and Spin Labels and Their Hydroxylamines
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115897 Aryl (Ethanoic) Propanoic Acid Ascorbyl Ester, Preparation Method Thereof And Medicament Containing The Same
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115883 Pyrimidine derivatives which are antagonists of the vitronectin receptor
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115872 Combination of a sodium-proton exchanger inhibitor and of a dihydro-1,3,5-triazine amine derivative
05/10/2012US20120115864 Substituted Fused Pyrimidine Compounds
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115859 3,4,5-substituted piperidines as renin inhibitors
05/10/2012US20120115856 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
05/10/2012US20120115854 Pharmaceutical composition containing antihypertensive agents
05/10/2012US20120115850 Substituted arylamine compounds and methods of treatment
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115843 Novel pyrrolidine derivatives
05/10/2012US20120115842 Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 1595